[Experimental myotonia with 20.25-diazacholesterol. Analysis of the phospholipids and cholesterol esters of the sarcoplasmic reticulum and the sarcolemma].
D000818:Animals; D001372:Aza Compounds / Q000009:adverse effects; D002784:Cholesterol / Q000032:analysis*; D002849:Chromatography, Gas; D002855:Chromatography, Thin Layer; D004195:Disease Models, Animal; D004952:Esters / Q000032:analysis; D005227:Fatty Acids / Q000032:analysis; D005260:Female; D008055:Lipids / Q000032:analysis; D009132:Muscles / Q000032:analysis; D009222:Myotonia / Q000139:chemically induced / Q000378:metabolism*; D010743:Phospholipids / Q000032:analysis*; D051381:Rats; D012508:Sarcolemma / Q000032:analysis*; D012519:Sarcoplasmic Reticulum / Q000032:analysis*
D001372:Aza Compounds; D004952:Esters; D005227:Fatty Acids; D008055:Lipids; D010743:Phospholipids; D002784:Cholesterol
Experimentelle Myotonie durch 20.25-Diazacholesterin. Analyse der Phospholipide und Cholesterinester des sarkoplasmatischen Retikulum und des Sarkolemm.